Vaccinating women against SARS-CoV-2 in mid to late pregnancy could provide their infants at least some protection against COVID-19 through six months of age, suggests a small study funded by the National Institutes of Health. Compared to infants born to mothers who had COVID-19 during pregnancy, infants born to vaccinated mothers were much more likely to have antibodies against the virus.
The District of Columbia Perinatal Quality Collaborative Grant is managed by the District of Columbia Hospital Association Program Services Company, Inc.
This DC Perinatal Quality Collaborative Grant Program is funded wholly or in part by the Government of the District of Columbia Department of Health.
